CRISPR-SID: Identifying EZH2 as a druggable target for desmoid tumors via in vivo dependency mapping
| Image |  |
|---|---|
| Description | scientific article published in 2021 |
| Author/s | |
| Publication date | November 17, 2021 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |